Associated Papers
The variation landscape of CYP2D6 in a multi-ethnic Asian population.
Maulana Y et al.
Scientific Reports, 2024
Resolving discordant CYP2D6 genotyping results in Thai subjects: platform limitations and novel haplotypes.
Hongkaew Y et al.
Pharmacogenomics, 2021
Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone.
Hongkaew Y et al.
Scientific Reports, 2021
Validation of an Extensive CYP2D6 Assay Panel Based on Invader and TaqMan Copy Number Assays.
Leung EKY et al.
The Journal of Applied Laboratory Medicine, 2017
Sequencing CYP2D6 for the detection of poor-metabolizers in post-mortem blood samples with tramadol.
Fonseca S et al.
Forensic Science International, 2016
Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.
Fang H et al.
The Pharmacogenomics Journal, 2014
LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias.
Johansen CT et al.
Journal of Lipid Research, 2014
24503134 (PubMed )
Supplement: supp_D045963_jlr.D045963-1.pdf
Length of psychiatric hospitalization is correlated with CYP2D6 functional status in inpatients with major depressive disorder.
Ruaño G et al.
Biomarkers in Medicine, 2013
Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.
Black JL et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2012
CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
Schaeffeler E et al.
Human Mutation, 2003
Select a paper to view details